Samuel Pine

Biography

Prior to joining BioAgilytix, Dr. Pine was Associate Director of Non-Clinical and Translational Sciences at Allergan, where he worked closely with drug safety scientists to develop novel protein therapeutics for ocular, neurologic, urologic, and dermatologic indications. He also garnered experience developing vaccines for a variety of infectious diseases through his previous positions with the Infectious Disease Research Institute, the HIV Vaccine Trial Network/Fred Hutchinson Cancer Research Center, and Novartis. Today Dr. Pine holds a patent as the co-inventor of “Composition and methods for stimulating an immune response against infectious agents”, has been published in numerous scientific journals, and actively contributes his insight to regulatory submission documents and peer-reviewed manuscripts. Prior to joining BioAgilytix, Dr. Pine was Associate Director of Non-Clinical and Translational Sciences at Allergan, where he worked closely with drug safety scientists to develop novel protein therapeutics for ocular, neurologic, urologic, and dermatologic indications. He also garnered experience developing vaccines for a variety of infectious diseases through his previous positions with the Infectious Disease Research Institute, the HIV Vaccine Trial Network/Fred Hutchinson Cancer Research Center, and Novartis. Today Dr. Pine holds a patent as the co-inventor of “Composition and methods for stimulating an immune response against infectious agents”, has been published in numerous scientific journals, and actively contributes his insight to regulatory submission documents and peer-reviewed manuscripts.

Research Interest

Biopharmaceutical Science, Business Management